LGALS1 and type 1 diabetes mellitus: Given that galectin-1 mediated a glycan-binding dependent suppressive effect on antigen-activated T cells, type 1 diabetes caused by beta-cell-reactive T cells and experimental autoimmune uveitis mediated by Th1 could be alleviated following application of galectin-1 [140,141].